These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Assembly stoichiometry of the GluK2/GluK5 kainate receptor complex. Reiner A; Arant RJ; Isacoff EY Cell Rep; 2012 Mar; 1(3):234-40. PubMed ID: 22509486 [TBL] [Abstract][Full Text] [Related]
10. Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310. Atlason PT; Scholefield CL; Eaves RJ; Mayo-Martin MB; Jane DE; Molnár E Mol Pharmacol; 2010 Dec; 78(6):1036-45. PubMed ID: 20837679 [TBL] [Abstract][Full Text] [Related]
11. Architecture and structural dynamics of the heteromeric GluK2/K5 kainate receptor. Khanra N; Brown PM; Perozzo AM; Bowie D; Meyerson JR Elife; 2021 Mar; 10():. PubMed ID: 33724189 [TBL] [Abstract][Full Text] [Related]
12. The structural arrangement and dynamics of the heteromeric GluK2/GluK5 kainate receptor as determined by smFRET. Litwin DB; Paudyal N; Carrillo E; Berka V; Jayaraman V Biochim Biophys Acta Biomembr; 2020 Jan; 1862(1):183001. PubMed ID: 31194959 [TBL] [Abstract][Full Text] [Related]
13. Functional Validation of Heteromeric Kainate Receptor Models. Paramo T; Brown PMGE; Musgaard M; Bowie D; Biggin PC Biophys J; 2017 Nov; 113(10):2173-2177. PubMed ID: 28935133 [TBL] [Abstract][Full Text] [Related]
14. Ligand binding is a critical requirement for plasma membrane expression of heteromeric kainate receptors. Valluru L; Xu J; Zhu Y; Yan S; Contractor A; Swanson GT J Biol Chem; 2005 Feb; 280(7):6085-93. PubMed ID: 15583001 [TBL] [Abstract][Full Text] [Related]
15. Domoic Acid as a Lead for the Discovery of the First Selective Ligand for Kainate Receptor Subtype 5 (GluK5). Buschbom-Helmke S; Wang P; Alcaide A; Miguez-Cabello F; Carta M; Viotti JS; Nielsen B; Mulle C; Bowie D; Jørgensen FS; Pickering DS; Bunch L J Med Chem; 2024 Aug; 67(16):14524-14542. PubMed ID: 39133077 [TBL] [Abstract][Full Text] [Related]
17. Assembly and intracellular distribution of kainate receptors is determined by RNA editing and subunit composition. Ball SM; Atlason PT; Shittu-Balogun OO; Molnár E J Neurochem; 2010 Sep; 114(6):1805-18. PubMed ID: 20626562 [TBL] [Abstract][Full Text] [Related]
18. A comparative analysis of kainate receptor GluK2 and GluK5 knockout mice in a pure genetic background. Iida I; Konno K; Natsume R; Abe M; Watanabe M; Sakimura K; Terunuma M Behav Brain Res; 2021 May; 405():113194. PubMed ID: 33631192 [TBL] [Abstract][Full Text] [Related]
19. Partial agonism in heteromeric GLUK2/GLUK5 kainate receptor. Paudyal N; Das A; Carrillo E; Berka V; Jayaraman V Proteins; 2025 Jan; 93(1):134-144. PubMed ID: 37526035 [TBL] [Abstract][Full Text] [Related]
20. Subunit-selective iGluR antagonists can potentiate heteromeric receptor responses by blocking desensitization. Pollok S; Reiner A Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25851-25858. PubMed ID: 32999066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]